Amylyx Pharmaceuticals, Inc. (AMLX) Earnings
|
Expand Research on AMLX
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +15.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q126 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/3/26 | Q425 | -$0.30 | -$0.34 | +$0.04 | N/A | $-52000000000 | N/A |  | | Details | |
| 11/6/25 | Q325 | -$0.37 | -$0.45 | +$0.08 | N/A | $52K | N/A | | | Details | |
| 8/7/25 | Q225 | -$0.46 | -$0.46 | $0.00 | N/A | N/A | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.42 | -$0.62 | +$0.20 | N/A | N/A | N/A | | | Details | |
| 3/4/25 | Q424 | -$0.55 | -$0.56 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 11/7/24 | Q324 | -$1.07 | -$0.70 | -$0.37 | $416K | N/A | N/A | | | Details | |
| 8/8/24 | Q224 | -$1.07 | -$0.73 | -$0.34 | N/A | $10.66M | N/A | | | Details |
